Eureka Globalstars Japan

28 Oct 2025 – 21 Jan 2026

Project cooperationUpdated on 4 November 2025

Novel biomarker for infectious disease

CEO & Co-founder at Bioeclosion SL

Cerdanyola del Valles, Spain

About

Bioeclosion SL has developed a novel, patented point-of-care device that delivers lab-quality results anywhere from a single drop of blood in just 10 minutes. We’re now seeking partners to apply and validate new biomarkers on the platform, enabling immediate, actionable insights so end users can act at the point of need.

Similar opportunities